期刊
ALIMENTARY PHARMACOLOGY & THERAPEUTICS
卷 16, 期 11, 页码 1843-1857出版社
WILEY
DOI: 10.1046/j.1365-2036.2002.01357.x
关键词
-
资金
- NCI NIH HHS [CA53801, CA97-004, CA93-16, CA63721] Funding Source: Medline
Colorectal cancer is the second leading cause of cancer death, after lung cancer, in the USA. The great majority (80%) of patients with colorectal cancer have sporadic disease with no evidence of having inherited the disorder. In the remaining 20%, a potentially definable genetic component exists. With the discovery of gene mutations related to hereditary colorectal cancer, risk assessment based on genetic test results is now feasible. The following review focuses on the two well-described colorectal cancer genetic syndromes-familial adenomatous polyposis and hereditary nonpolyposis colorectal cancer, the process of genetic counselling, currently available genetic tests, and indications for their use.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据